Apollo Hospitals Enterprise Limited — Board Meeting, 12-08-2025: Outcome of Board Meeting

Apollo Hospitals' board meeting yielded strong Q1 FY26 results: Consolidated Revenue jumped 15% YoY to ₹5,842 Cr, EBITDA grew 26% to ₹852 Cr, and PAT surged 42% to ₹433 Cr. The company is acquiring the remaining 50% stake in Apollo Gleneagles PET-CT for ₹8.5 Cr, making it a wholly-owned subsidiary. Significant progress continues on the demerger of its omni-channel pharmacy and digital health business into Apollo Healthtech Ltd., aiming to unlock shareholder value. The company also outlined plans to add over 4,300 beds in the next five years with a ₹7,600 Cr investment, indicating robust growth ahead.